Cancer Treatment Centers of America

Newnan, Georgia 30265

0 studies enrolling now · 12 studies all time

What they study most

Advanced Squamous Non-Small Cell Lung Carcinoma, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors, Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers, Breakthrough Cancer Pain, Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression, Cholangiocarcinoma, Early Stage HER2+ Breast Cancer, Gastric Cancer, HER2 Positive Breast Cancer, Lung Lesion(s) Requiring Evaluation, Non Small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study of TAS-120 in Patients With Advanced Solid Tumors — Completed
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed
• RBN-2397 in Combination With Pembrolizumab in Patients With SCCL — Status unconfirmed
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread — Stopped early
• Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors — Stopped early
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide — Completed
• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early
• NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™ — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed
• Observational Registry Study of Quality of Life When Treating BTcP With Abstral — Completed